By Ed SilvermanMay 8, 2026 Pharmalot Columnist, Senior Writer Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageAI Generated
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/2cf0d2d7-bde6-4f45-b6bb-e8dfac6fe25e)